We are live on ! Find out more
TLSIW icon

TriSalus Life Sciences Warrant
TLSIW

24 hedge funds and large institutions have $238K invested in TriSalus Life Sciences Warrant in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

17% less funds holding

Funds holding: 29 → 24 (-5)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

91% less capital invested

Capital invested by funds: $2.59M → $238K (-$2.35M)

Holders
24
Holders Change
-5
Holders Change %
-17.24%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
5
Calls
$1.48M
Puts
–
Net Calls
+$1.48M
Net Calls Change
+$988K

Top Buyers

1
CF
Cantor Fitzgerald
New York
+$5.44K
2
FTUS
Flow Traders U.S.
New York
+$918
3
FSI
Flow State Investments
Illinois
+$438

Top Sellers

1
CS
Clear Street
New York
-$21.4K
2
AGC
Angelo Gordon & Co
New York
-$8.45K
3
IM
Islet Management
New York
-$4.89K
4
AGM
Alpine Global Management
New York
-$1K
5
OMC
Old Mission Capital
Illinois
-$935
Name Holding Trade Value Shares
Change 		Change in
Stake
MF
1
Magnetar Financial
Illinois
$96.1K – – –
DM
2
Deerfield Management
New York
$20.5K – – –
PAMP
3
Polar Asset Management Partners
Ontario, Canada
$17.6K – – –
KL
4
KIM LLC
Kansas
$13.3K – – –
RCM
5
Radcliffe Capital Management
Pennsylvania
$11.1K – – –
VI
6
Vestcor Inc
New Brunswick, Canada
$9K – – –
MP
7
MSD Partners
New York
$8.19K – – –
Point72 Asset Management
8
Point72 Asset Management
Connecticut
$8.19K – – –
Balyasny Asset Management
9
Balyasny Asset Management
Illinois
$7.59K – – –
Walleye Capital
10
Walleye Capital
New York
$6.42K -$97 -1,100 -1%
BCL
11
Bracebridge Capital LLC
Massachusetts
$6.07K – – –
HCM
12
Highbridge Capital Management
New York
$5K – – –
SCM
13
Shaolin Capital Management
Florida
$5K – – –
AA
14
AQR Arbitrage
Connecticut
$4.09K – – –
CCM
15
Context Capital Management
California
$4K – – –
FFAM
16
Forge First Asset Management
Canada
$3.94K – – –
CF
17
Cantor Fitzgerald
New York
$3.79K +$5.44K +61,658 New
CM
18
CastleKnight Management
New York
$2.82K – – –
Jane Street
19
Jane Street
New York
$1.38K – – –
HF
20
HRT Financial
New York
$1K -$9 -100 -0.3%
FTUS
21
Flow Traders U.S.
New York
$1K +$918 +10,405 New
FSI
22
Flow State Investments
Illinois
$921 +$438 +4,967 +50%
Nomura Holdings
23
Nomura Holdings
Japan
$648 – – –
ETH
24
Exos TFP Holdings
New York
$574 -$77 -869 -9%
CS
25
Clear Street
New York
$6 -$21.4K -242,241 -100%
1
2

TLSIW Hedge Fund Activity: Q1 2023 in Review

24 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in TriSalus Life Sciences Warrant (TLSIW) for Q1 2023, worth a combined $238K — down 91% from $2.59M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of TLSIW and 2 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Cantor Fitzgerald, opening a new position worth an estimated $5.44K. The largest seller was Clear Street, cutting an estimated $21.4K.

  • 24 institutional investors held TriSalus Life Sciences Warrant (TLSIW) as of Q1 2023, down from 29 in Q4 2022.
  • Funds reported $238K of TriSalus Life Sciences Warrant stock for Q1 2023, down 91% quarter-over-quarter.
  • 2 funds opened new TriSalus Life Sciences Warrant positions in Q1 2023 and 5 closed out, a net change of -3 holders.
  • The largest TriSalus Life Sciences Warrant buyer in Q1 2023 was Cantor Fitzgerald, an estimated $5.44K added.
  • The largest TriSalus Life Sciences Warrant seller in Q1 2023 was Clear Street, an estimated $21.4K sold.

Based on aggregated 13F filings for Q1 2023.